A few recent fragments
How can you proactively scan, adapt, and act?
Here’s a small collection of moments, sketches, or ideas. Some finished, some still figuring themselves out.
See the Fast Five #2
Familiarize yourself with the latest Canadian policies.
-
+
In the broader context of global uncertainty, drug manufacturers must simultaneously navigate a series of new domestic drug pricing policies that actually strive for the opposite objective of the US: making drug prices lower. Companies here need to understand what these policies mean for them, including:
Patented Medicine Prices Review Board (PMPRB) — Canada’s unique form of drug price regulation specific to patented medicines. In the past, guidelines benchmarked Canadian drug prices against the highest international price in seven other countries. Now, that list has grown to 11 and excludes the US. Exceeding PMPRB price thresholds can result in lengthy investigations, price uncertainty, and financial penalties.
Pharmacare — Canada recently enacted legislation for the staged implementation of publicly funded, single-payer, universal drug coverage for Canadians. Under Canada’s current drug benefit regime, most Canadians receive private drug insurance from their employers, or from the public regimes governed by individual provinces and territories. To date, pharmacare funding has been limited to contraception and diabetes products, and only certain provinces have agreed to participate. Canada has also been consulting on a list of other essential medicines and a bulk purchasing strategy to further expand Pharmacare coverage with the hopes of negotiating lower drug prices.
Weave compliance right into innovation.
-
+
Everyone in the organization needs to understand the role compliance plays in successful innovation. Making compliance the common thread (through internal engagement, communication, education) across the enterprise and at the Board level is essential. Compliance cannot be a box that the Chief Risk Officer checks at the end of the process; it’s something that must be considered every step of the way — especially in emerging areas of the sector.
Stay informed.
-
+
Regulation is evolving at speeds the industry isn’t used to. Energy and infrastructure organizations will need to adapt, creating new means of staying ahead of change, understanding what’s happening, and never underestimating the potential impacts on everything from project review and approvals to reporting and compliance requirements.
Ensure business practices evolve with the law.
-
+
This will reduce exposure to claims, while fostering the kind of goodwill and business opportunities industry leaders value.